Podoplanin is a novel fos target gene in skin carcinogenesis

Cancer Research

Volumn 68, Issue 17, 2008, Pages 6877-6883

  Durchdewald, Moritz ^a   Guinea Viniegra, Juan ^b,c   Haag, Daniel ^a   Riehl, Astrid ^a   Lichter, Peter ^a   Hahn, Meinhard ^a   Wagner, Erwin F ^b,c   Angel, Peter ^a   Hess, Jochen ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^c Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PODOPLANIN; PROTEIN C FOS; PROTEIN FOS; GP38 PROTEIN, MOUSE; MEMBRANE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER MODEL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE ACTIVITY; GENE DELETION; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; KERATINOCYTE; MOUSE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN BINDING; REAL TIME POLYMERASE CHAIN REACTION; SKIN CANCER; SKIN CARCINOGENESIS; ANIMAL; CANCER INVASION; CELL TRANSFORMATION; DISEASE COURSE; GENETICS; ONCOGENE; PATHOLOGY; SKIN TUMOR;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; GENES, FOS; MEMBRANE GLYCOPROTEINS; MICE; NEOPLASM INVASIVENESS; SKIN NEOPLASMS;

EID: 52049088930     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-0299     Document Type: Article

References (28)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
2. Wagner EF. AP-1 reviews. Oncogene 2001;20:2333-497.
3. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991;1072:129-57.
4. Eferl R, Wagner EF. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 2003;3:859-68.
5. Cooper SJ, MacGowan J, Ranger-Moore J, Young MR, Colburn NH, Bowden GT. Expression of dominant negative c-jun inhibits ultraviolet B-induced squamous cell carcinoma number and size in an SKH-1 hairless mouse model. Mol Cancer Res 2003;1:848-54.
6. Young MR, Yang HS, Colburn NH. Promising molecular targets for cancer prevention: AP-1, NF-κ B and Pdcd4. Trends Mol Med 2003;9:36-41.
7. Saez E, Rutberg SE, Mueller E, et al. c-fos is required for malignant progression of skin tumors. Cell 1995;82:721-32.
8. Gerdes MJ, Myakishev M, Frost NA, et al. Activator protein-1 activity regulates epithelial tumor cell identity. Cancer Res 2006;66:7578-88.
9. Reichmann E, Schwarz H, Deiner EM, et al. Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion. Cell 1992;71:1103-16.
10. Gandarillas A, Scholl FG, Benito N, Gamallo C, Quintanilla M. Induction of PA2.26, a cell-surface antigen expressed by active fibroblasts, in mouse epidermal keratinocytes during carcinogenesis. Mol Carcinog 1997;20:10-8.
11. Schacht V, Dadras SS, Johnson LA, Jackson DG, Hong YK, Detmar M. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol 2005;166:913-21.
12. Wicki A, Lehembre F, Wick N, Hantusch B, Kerjaschki D, Christofori G. Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell 2006;9:261-72.
13. Scholl FG, Gamallo C, Quintanilla M. Ectopic expression of PA2.26 antigen in epidermal keratinocytes leads to destabilization of adherens junctions and malignant progression. Lab Invest 2000;80:1749-59.
14. Fleischmann A, Hvalby O, Jensen V, et al. Impaired long-term memory and NR2A-type NMDA receptor-dependent synaptic plasticity in mice lacking c-Fos in the CNS. J Neurosci 2003;23:9116-22.
15. Sibilia M, Fleischmann A, Behrens A, et al. The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development. Cell 2000;102:211-20.
16. Tarutani M, Itami S, Okabe M, et al. Tissue-specific knockout of the mouse Pig-a gene reveals important roles for GPI-anchored proteins in skin development. Proc Natl Acad Sci U S A 1997;94:7400-5.
17. Rhiemeier V, Breitenbach U, Richter KH, et al. A novel aspartic proteinase-like gene expressed in stratified epithelia and squamous cell carcinoma of the skin. Am J Pathol 2006;168:1354-64.
18. Schreiber M, Baumann B, Cotten M, Angel P, Wagner EF. Fos is an essential component of the mammalian UV response. Embo J 1995;14:5338-49.
19. Schreiber M, Kolbus A, Piu F, et al. Control of cell cycle progression by c-Jun is p53dependent. Genes Dev 1999;13:607-19.
20. Durchdewald M, Beyer TA, Johnson DA, Johnson JA, Werner S, auf dem Keller U. Electrophilic chemicals but not UV irradiation or reactive oxygen species activate Nrf2 in keratinocytes in vitro and in vivo. J Invest Dermatol 2007;127:646-53.
21. van Dam H, Huguier S, Kooistra K, et al. Autocrine growth and anchorage independence: two complementing Jun-controlled genetic programs of cellular transformation. Genes Dev 1998;12:1227-39.
22. Hess J, Porte D, Munz C, Angel P. AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent matrix metalloproteinase 13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1 composite lement. J Biol Chem 2001;276:20029-38.
23. Porte D, Tuckermann J, Becker M, et al. Both AP-1 and Cbfa1-like factors are required for the induction of interstitial collagenase by parathyroid hormone. Oncogene 1999;18:667-78.
24. Hummerich L, Muller R, Hess J, et al. Identification of novel tumour-associated genes differentially expressed in the process of squamous cell cancer development. Oncogene 2006;25:111-21.
25. Schlingemann J, Hess J, Wrobel G, et al. Profile of gene expression induced by the tumour promotor TPA in murine epithelial cells. Int J Cancer 2003;104:699-708.
26. Darwiche N, Ryscavage A, Perez-Lorenzo R, et al. Expression profile of skin papillomas with high cancer risk displays a unique genetic signature that clusters with squamous cell carcinomas and predicts risk for malignant conversion. Oncogene 2007;26:6885-95.
27. Ordway JM, Williams K, Curran T. Transcription repression in oncogenic transformation: common targets of epigenetic repression in cells transformed by Fos, Ras or Dnmt1. Oncogene 2004;23:3737-48.
28. Grigoriadis AE, Schellander K, Wang ZQ, Wagner EF. Osteoblasts are target cells for transformation in c-fos transgenic mice. J Cell Biol 1993;122:685-701.